# A Controlled Study to Evaluate the Safety and Immunogenicity of StreptAnova™ in Healthy Adults

> **NCT02564237** · PHASE1 · UNKNOWN · sponsor: **Dalhousie University** · enrollment: 39 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** StreptAnova™ (Group A streptococcal (GAS) vaccine)
- **BIOLOGICAL:** Hepatitis B vaccine
- **BIOLOGICAL:** Hepatitis A vaccine
- **BIOLOGICAL:** Human Papillomavirus vaccine

## Key facts

- **NCT ID:** NCT02564237
- **Lead sponsor:** Dalhousie University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-08
- **Primary completion:** 2017-03
- **Final completion:** 2017-12
- **Target enrollment:** 39 (ACTUAL)
- **Last updated:** 2017-01-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02564237

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02564237, "A Controlled Study to Evaluate the Safety and Immunogenicity of StreptAnova™ in Healthy Adults". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02564237. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*